C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Sells 42 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors lowered its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 5.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 704 shares of the biotechnology company’s stock after selling 42 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors’ holdings in Axon Enterprise were worth $418,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Stratos Wealth Advisors LLC bought a new position in shares of Axon Enterprise in the third quarter worth about $259,000. Blue Trust Inc. increased its position in Axon Enterprise by 234.5% during the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company’s stock worth $116,000 after purchasing an additional 204 shares in the last quarter. Foundations Investment Advisors LLC bought a new position in Axon Enterprise in the 3rd quarter valued at approximately $221,000. Sequoia Financial Advisors LLC boosted its position in Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after buying an additional 81 shares in the last quarter. Finally, Signaturefd LLC grew its stake in shares of Axon Enterprise by 16.3% during the third quarter. Signaturefd LLC now owns 655 shares of the biotechnology company’s stock worth $262,000 after buying an additional 92 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on AXON shares. JMP Securities raised their price objective on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a report on Tuesday, February 4th. Robert W. Baird lifted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $542.15.

Axon Enterprise Stock Performance

Shares of AXON opened at $593.42 on Thursday. The firm’s fifty day simple moving average is $624.50 and its two-hundred day simple moving average is $515.36. Axon Enterprise, Inc. has a 12 month low of $260.27 and a 12 month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $45.25 billion, a P/E ratio of 153.34, a price-to-earnings-growth ratio of 6.85 and a beta of 1.05.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now directly owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 in the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.